Data Vantage: Axcynsis, Morning and Pintarnya report funding updates

Data Vantage: Axcynsis, Morning and Pintarnya report funding updates

Axcynsis Therapeutics, a Singapore-based biotech startup that develops antibody-drug conjugates (ADCs) for cancer therapy and was formerly known as Tetris Therapeutics, received $10 million last week as part of a $15 million seed round announced in May.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter